| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.5 | 0.08 |